This site is intended for health professionals only
During Pulse PCN Events, you will also have the opportunity to find out more about the latest innovations from our handpicked selection of suppliers. By clicking on the logo you will be able to access their websites and learn more about the latest products and services.
If you are interested in participating, please contact us.
Interested in exhibiting?
Sleepio is the NICE-recommended, cost-saving treatment for insomnia based on Cognitive Behavioural Therapy (CBT) – finally giving clinicians and patients an alternative to hypnotics.
Built by clinical experts and rigorously tested in 14 Randomised Controlled Trials, Sleepio is proven to be safe and effective in tackling insomnia.
Count on us to keep them in the moment
At Daiichi Sankyo UK, we create and supply innovative products to help the NHS to deliver better patient care in the fields of cardiovascular disease and oncology.
Our mission is to contribute to the enrichment of quality of life through the discovery and delivery of innovative medicines that address diverse and unmet medical needs.
For more information visit https://www.daiichi-sankyo.co.uk
Transforming Primary Care and Population Health through digital-first patient engagement
Underpinned by one technology platform, iPLATO enables high-impact, multi-channel patient engagement at population-wide scale to tailored individual communications with tools including patient questionnaires, remote consultation, web booking, friends and family tests, triage and NHS App integrations to deliver cost savings.
iPLATO’s solutions transform overburdened and fragmented healthcare routes into streamlined digital-first pathways leading with effective digital patient engagement. Today, we serve thousands of GP practices and millions of patients.
Doccla is a CQC accredited tech-enabled virtual ward and remote patient monitoring company. Founded in 2018, we have since maintained an unwavering ambition to supply the very best patient monitoring service with the highest levels of clinician and patient satisfaction. We provide our clients with comprehensive support, which frees them from worrying about implementation, technology, logistics and patient compliance. We take care of every detail to allow clinicians to focus on what they do best, caring for patients. Our service is proven to reduce costs for a wide range of pathways, improving outcomes and freeing resources.
As a global leader in allergy and autoimmune disease diagnostics, Thermo Fisher ImmunoCAP™ are committed to providing accurate, clinically relevant testing solutions to aid in proper disease diagnosis and patient management. With more than 550 whole allergens and allergen mixes, and 100 allergen component tests available, our products are documented in more than 6,000 publications and referenced in multiple health guidelines. These may be some of the reasons for ImmunoCAP™ being acknowledged as the gold standard technology for specific IgE blood testing, particularly for identifying asthma and rhinitis triggers and whole food and component allergens.
GSK is a global biopharma company with the ambition and purpose to unite science, technology and talent to get ahead of disease together.
We aim to positively impact the health of 2.5 billion people over the next 10 years.
Our vaccines portfolio is the broadest in the industry, helping to protect people over the course of their lives.
Two million of our vaccines are administered every day, and 40% of the world’s children receive a GSK vaccine each year.
Flynn Pharma is a privately held pharmaceutical company with a track record in delivering essential medicines to adult and paediatric patients through primary care, secondary care and specialist medicine.
We work across a wide range of therapy areas including psychiatry, paediatric medicine, post-operative pain management, anti-infective and emergency medicine. We supply both branded and generic medicines including a range of injectable and oral antibiotics.
At Flynn Pharma, we provide essential medicines for patients with specific needs, often by re-discovering and working with established speciality drugs and branded pharmaceutical products. We are proud to make a positive difference to patients through introducing new products, improving existing formulations or adding new indications.
Flynn Pharma is a dynamic and responsible in-licensing partner for companies interested in successfully supplying medicines to the UK or EU pharmaceutical markets. We have significant experience and capability in creating and implementing compelling branded campaigns, that deliver industry leading results in key therapy areas. Our commitment to collaboration, aligned with our capability and agility, has enabled us to deliver value to our partners across primary care, secondary care, and specialist medicine.
An award-winning dynamic healthcare organisation.
Core Prescribing Solutions is a dynamic fast-paced healthcare organisation with over 25 years’ combined experience in the NHS, primary care, health informatics and the pharmacy sector.
We provide tailor-made primary care packages through a fully managed pharmacist or technician-led model suited to the needs of Primary Care Networks (PCNs), GP practices and clients to help reduce workloads and streamline processes.
We offer real-life, data-driven solutions to improve patient outcomes and digitise healthcare.
Our mission is to improve mental health with these new treatment options, giving healthcare professionals immediate solutions for their treatment strategies and patient’s care pathways, starting with its first digital therapy, deprexis®, for the treatment of depression.
Providing access to digital therapy for both Primary Care and Talking Therapy services, EDT is already making a difference with the implementation of pilot projects in PCNs to demonstrate the patient and system benefits of deprexis®.
Brought to you by our portfolio of market-leading brands, Pulse, Nursing in Practice and Management in Practice, Pulse Practice Jobs sits at the heart of general practice recruitment.
Whether you are looking for a permanent or locum position, in the UK or abroad, Pulse Practice Jobs has 100s of GP, practice nurse and practice manager vacancies to help power your next career move. Filter your search by job title, salary, location or sector, and ensure you are the first to hear about the latest vacancies by signing up for tailored job alert emails, straight to your inbox.
The WaveSense JAZZ™ test strip is used in the WaveSense JAZZ™ blood glucose monitoring systems. It has been a popular choice of Commissioners and HCPs for many years, resulting in it being the 2nd most prescribed test strip in the UK. AgaMatrix have worked hard to secure this position by offering high quality, accurate blood glucose testing combined with second-to-none support.
Find out more about our recently launched ALLY Diabetes Management System. The system consists of ALLY Home for patients and ALLY Local for GP Practices and Community Diabetes Teams and enables the sharing of data for easier diabetes management.
Trudell Medical International works with patients, their caregivers and healthcare professionals to help patients all over the world breathe better and live fuller lives. We manufacture and globally market some of the leading brands in respiratory care including the AeroChamber* brand of spacers, Aerobika* OPEP devices, and AEROECLIPSE* BAN* nebulizers.
About Optum®
Optum® UK uses advanced analytics, digital products and advisory services to help make health and care systems work better for everyone.
Optum has been connecting with health and care in the UK since 2002.
Our expertise
Our team is exclusively health and care focused and has a wealth of practical real-world experience running and supporting health and care systems globally.
Clinically led, we ensure our customers benefit from relevant value-based care solutions to any challenge. We engage stakeholders at every level of a System to help turn strategies into effective operational plans to benefit the populations they serve.
With Diabetes, Knowledge Is Power:
At Dexcom we’ve spent the last 20 years innovating and developing simpler and better ways for people with diabetes to measure, track and manage their diabetes. Why? Because we believe data has the power to make life with diabetes, better.
Headquartered in San Diego, California, Dexcom has emerged as a leader of diabetes care technology.
Gedeon Richter have a presence in over 100 countries worldwide and have been working to change lives for the better since 1901. We are one of the few companies in the world to offer a comprehensive portfolio for women; our R&D team continue to innovate and extend our gynaecological, fertility and osteoporosis portfolio, aiming to address women’s healthcare needs in these areas. Our ambition is to help women achieve theirs.
April 2022, UK-GED-2200035
Prescribing Care Direct is a primary care clinical pharmacist service provider that offers comprehensive managed clinical pharmacy services to healthcare organisation’s across the United Kingdom. PCD aims to develop and deliver a high-quality medicines optimisation and fully managed pharmacy service to GP surgeries and PCNs nationwide. Prescribing Care Direct can help unlock surgeries ARRS funding to ensure that it is used in the most cost effective and clinically efficient manner.
Find out more from our website www.prescribingcaredirect.co.uk or get in touch today via email: [email protected]
At Think Healthcare we’re passionate about helping patients by empowering practices to create a communication ecosystem that improves the experience of both.
We want to help patients have a smoother & more seamless experience accessing NHS services with minimal wait.
We want to help practices to manage demand, save time, work flexibly, and save money.
The Think Healthcare cloud telephony platform is managed by NHS experts who really care about each and every practice, and work hard to make sure your solution is customised to your individual needs.
X-on is an award winning pioneer of digital telephony in the UK, delivering simple but powerful communications choices to the NHS and healthcare. The digital and online ambitions of the NHS are addressed by providing secure, flexible, scalable, cost-effective telephony and video solutions, tailored by feedback from healthcare professionals.
Deployed across over 1800 UK practices, Surgery Connect is a future proof, secure GP telephony solution which improves the patient experience, while driving efficient practice management and scalable communications across General Practice, PCNs and CCGs. Surgery Connect provides fully integrated remote working for GPs and staff via mobiles and softphone.
Surgery Connect provides quick switching between audio and video during a call with a patient, with calls recorded and call data attached to the patient record. A full suite of web browser based Management Consoles provide a real time view of call levels and staff activity, access to call flow management and extensive analytical reporting. Integration ensures practitioners are not switching between a patchwork of discrete applications.
The Phonebar is an innovative App, pinned to the bottom of the PC screen, which brings all telecoms onto the desktop for easy access.
Surgery Connect integrates with most clinical systems, providing a seamless and time-saving way in which clinical and admin staff can access and record patient information during a call. Surgery Connect has been tailored by feedback from healthcare professionals ensuring a system that uniquely serves the needs of GP Practices, while addressing the digital and online ambitions of the NHS.
FDB (First Databank), part of the Hearst Health network, is the leading provider of drug knowledge that helps healthcare professionals make precise decisions. With thousands of customers worldwide, FDB enables our information system developer partners to deliver valuable, useful, and differentiated solutions. We offer four decades of experience in transforming medical knowledge into actionable, targeted, and effective solutions that help improve patient safety, operational efficiency, and healthcare outcomes.
Symprove is a water-based probiotic that delivers billions of live and active bacteria to the gut. The healthy bacteria arrive safely in the gut, surviving the harsh environment of the stomach, before multiplying rapidly, thriving and colonising in the gut. This process has been scientifically proven by independent clinical trials in collaboration with research partners including University College London and King’s College London. With existing studies in IBS and IBD completed, Symprove and its key research partners have several more studies underway, including new research on IBS, which will be published in 2023.
Having gained an impressive and loyal customer base since its launch to the market (9 out of 10 customers would recommend), alongside backing from clinical experts, Symprove allows people to take control of their gut and currently boasts an impressive 5* TrustPilot score.
The product is vegan, gluten free and FODMAP-friendly.
Symprove is a unique water-based probiotic that works differently to dairy or tablet formulas to deliver live bacteria to the colon. Proven in randomised controlled trials at King’s College Hospital and independent in-vitro studies at University College London, 92% of people feel the difference in real-world.
Facebook: https://www.facebook.com/Symprove/
Instagram: https://www.instagram.com/symproveyourlife/?hl=en
Twitter: https://twitter.com/symprove
LinkedIn: https://www.linkedin.com/company/symprove/?originalSubdomain=uk
Anima is the next generation online consultation platform for PCNs and GP practice teams. Anima provides PCNs and practice teams with everything you need to manage any patient request end-to-end in a single platform. Unprecedented levels of control, customisation and automation and productivity tools help supercharge your entire team and co-ordinate great care across your organisation. Built by doctors, approved by NHS Digital, and integrated with EMIS & SystmOne, Anima really is the “most advanced GP consultation platform around” (eGPlearning).
Pfizer Vaccines: Protecting life’s journey
Our history in vaccines stretches as far back as 1882. Today, our organisation is comprised of passionate, world-class employees who work every day to translate cutting-edge science into vaccines that improve people’s lives.
We have a portfolio of vaccines that helps protect individuals from life-threatening diseases such as pneumococcal and meningococcal disease at every stage of their life, from their first months to old age, including travel vaccines.
Contact us at [email protected] or 0800-089-4033
PP-UNP-GBR-0816 May 2022
Livi’s mission is to build better, more accessible healthcare for everyone. We place patient access and equality at our core as we fast-forward the future of healthcare. Clinician and employee wellbeing are key focus for the organisation, with flexibility, support and a healthy work/life balance imperative to ensuring a positive working environment.
Livi is rated Outstanding by the CQC, and through NHS partnerships enables more than six million patients to see GP’s and other health professionals by video consultation. Livi is the UK arm of Kry, Europe’s leading digital healthcare company. Find out more at Livi.co.ukLivi’s mission is to build better, more accessible healthcare for everyone. Our service is used by more than 4,500 GP practices in the UK, and through partnerships with the NHS, enables more than eleven million patients to see GPs and other health professionals by video. Livi is rated Outstanding by the Care Quality Commission and is the highest-rated digital health app in the iOS App Store. Livi is the UK arm of Kry, Europe’s leading digital healthcare company. Livi also offers a patient batch-messaging and remote monitoring platform, Mjog, currently used in 40% of GP practices in the UK.
Pioneer in its field, Echosens significantly changed the practice of liver diagnosis with FibroScan®, the first non-invasive solution to assess and monitor patients with chronic liver disease. FibroScan® is recognized worldwide as the reference for non-invasive liver fibrosis and liver steatosis assessment with more than 3,500+ peer reviewed publications and 160+ international guidelines recommendations. Echosens has made FibroScan® available in over 100+ countries enabling millions of liver examinations worldwide.
Essential to effective practice management is communications. A good communications system provides patients with easy access to their GP Practice, along with collaborative tools that maximise staff efficiency by reducing time spent on admin and connecting with patients. An omnichannel approach with ‘everything under one roof’ – telephony, video, SMS, clinical systems, remote working – all integrated seamlessly, will best serve the needs of patients, practitioners, staff and allow managers to address the digital ambitions of the NHS.
With continual input from GPs, Practice Managers and IT Leads over many years, Surgery Connect has been built from the ground up to become the only telephony solution that addresses the specific needs of General Practice. A per extension rental model helps managers reduce and more easily manage costs. Surgery Connect guarantees more efficient practice management, and scalability supports growth across PCNs, GP Federations and CCGs while delivering the integrated care agenda.
Redmoor Health uses innovative digital technology solutions to promote an agile collaborative working environment. We have a proven track record of supporting organisations to embed a range of technological products into services. Redmoor Health specialises in the application of technology across health and social care, and in designing, developing, and implementing sustainable digital health solutions for both patients and staff. Our latest product the Digital Journey Planner is now available to practices across the UK for free. We offer support throughout the digital journey – from strategy development and training to implementation. Our offer includes the only fully implemented PCN E-hub model in the UK.
As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach nearly 800 million people globally and we are finding innovative ways to expand access to our latest treatments. About 110,000 people of more than 140 nationalities work at Novartis around the world.
In the UK, we employ approximately 1,300 people to serve healthcare needs across the whole of the UK, as well as supporting the global operations of Novartis. Since 2014, Novartis has invested over £200 million in R&D and is the single largest industry sponsor of clinical trials in the UK. For more information, please visit www.novartis.co.uk
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. AstraZeneca operates in over 100 countries and its medicines are used by millions of patients worldwide.
With a proud 100-year heritage in advancing UK science, today AstraZeneca is the UK’s leading biopharmaceutical company. AstraZeneca is based in six different locations across the UK, with its global headquarters in Cambridge. In the UK, around 8,600 employees work in research and development, manufacturing, supply, sales and marketing. We supply around 35 different medicines to the NHS.
For more information, please visit www.astrazeneca.co.uk and follow us on Twitter @AstraZenecaUK.
LumiraDx is transforming community-based healthcare by providing fast, accurate and comprehensive diagnostic information at the point of need, enabling better medical decisions that lead to improved outcomes at a lower cost.
The company’s innovative LumiraDx Platform is designed to perform a broad menu of tests including infectious disease, cardiovascular disease, diabetes, and coagulation disorders and deliver lab-comparable performance with results in less than 12 minutes.
Founded in 2014, LumiraDx is based in the UK with R&D and manufacturing sites across the US and Europe. For more information, please visit www.lumiradx.com.
